FutureFuel Corp.
For the period ended Jun 30, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 10, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-11.
0001437749-26-016116
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-10.
0001437749-26-026784
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 61 previous paragraphs and 65 current paragraphs.
42 unchanged; 19 reworded; 3 added; 0 removed; 0 previous and 1 current paragraphs rearranged.
Tables are not compared: 12 previous and 11 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (3)
Current report
On June 30, 2026, the Company contracted with Freepoint Commodities to sell its 2025 CFPC and Small Agri-Biodiesel Producer Tax Credits which were $2,725 net of fees. The Company recognized a receivable for the 2025 credits. The Company also committed to sell its 2026 credits which were $6,733 as of June 30, 2026. The 2026-2029 tax credits will be monetized at each fiscal year end with an early draw provision subject to financing fees.
Current report
** Adjusted to reflect the change in accounting methodology from LIFO to moving average for inventory valuation. See Note 1 to our consolidated financial statements for additional information.*
Current report
Consolidated revenue in the six months ended June 30, 2026, increased 108% or $57,467 compared to the six months ended June 30, 2025. The change in volume and product mix of $25,250 was largely due to growth in the chemical segment's energy market products adding $17,427 as noted above. The biofuel segment added $7,823 from energy market performance and regulatory clarity.
Reworded paragraphs (19)
Previous wording
The biodiesel segment was supported by the United States Environmental Protection Agency (“EPA”) Renewable Fuel Standard (“RFS”). We generate 1.5 Renewable Identification Numbers (“RINs”) for each gallon of biodiesel sold in the United States with a classification of a D4 or D6 RIN. RINs are used to monitor the level of renewable fuel traded in a given year in accordance with RFS within the EPA moderated transaction system. We do not assign cost of goods sold to the generation of RINs as the physical fuel generates the full cost. As of March 31, 2026, we held 0.2 million D4 RINs with a fair market value of $298. Comparatively, as of March 31, 2025, we held 2.3 million D4 RINs with a fair market value of $2,077.
Current wording
The biodiesel segment was supported by the United States Environmental Protection Agency (“EPA”) Renewable Fuel Standard (“RFS”). We generate 1.5 Renewable Identification Numbers (“RINs”) for each gallon of biodiesel sold in the United States with a classification of a D4 or D6 RIN. RINs are used to monitor the level of renewable fuel traded in a given year in accordance with RFS within the EPA moderated transaction system. We do not assign cost of goods sold to the generation of RINs as the physical fuel generates the full cost. As of June 30, 2026, we held 0.1 million D4 RINs with a fair market value of $210. Comparatively, as of June 30, 2025, we held 0.5 million D4 RINs with a fair market value of $604.
Previous wording
On February 4, 2026, the Treasury Department and the Internal Revenue Service issued proposed regulations providing expanded guidance on the clean fuel production credit (“CFPC”) integrating changes from the Budget Reconciliation Act of 2025, which made modifications to the CFPC. The proposed rule is expected to help level the competitive environment for biodiesel by: (i) reducing the tax credit for sustainable aviation fuel from $1.75 per gallon to $1.00 per gallon effective January 1, 2026, and (ii) requiring that all feedstock be sourced from North America, as required for biomass-based diesel.
Current wording
On February 4, 2026, the Treasury Department and the Internal Revenue Service issued proposed regulations providing expanded guidance on the clean fuel production credit (“CFPC”) integrating changes from the Budget Reconciliation Act of 2025, which made modifications to the CFPC. The proposed rule is expected to help level the competitive environment for biodiesel by: (i) reducing the tax credit for sustainable aviation fuel from $1.75 per gallon to $1.00 per gallon effective January 1, 2026, and (ii) requiring that all feedstock be sourced from North America, as required for biomass-based diesel. On June 12, 2026, the Department of Energy released the updated 45ZCF-GREET model to help biofuel producers calculate carbon intensity for the CFPC.
Previous wording
The following table reconciles net (loss) income, the most directly comparable GAAP performance financial measure, with adjusted EBITDA.
Current wording
The following table reconciles net income (loss), the most directly comparable GAAP performance financial measure, with adjusted EBITDA.
Previous wording
Consolidated revenue in the three months ended March 31, 2026, increased 82% or $14,414 compared to the three months ended March 31, 2025, driven by two factors
Current wording
Consolidated revenue in the three months ended June 30, 2026, increased 121% or $43,053 compared to the three months ended June 30, 2025, primarily driven by two factors:
Previous wording
Gross loss in the three months ended March 31, 2026, increased $670 as compared to the same period of 2025. This variance was primarily driven by two factors:
Current wording
Gross profit (loss) in the three and six months ended June 30, 2026, improved $27,416 and $26,746, respectively, as compared to the same periods of 2025. This variance was primarily driven by growth in the chemical segment, energy regulatory clarity in the biofuel segment, and energy market performance in both segments.
Previous wording
Operating expenses increased $710 in the three months ended March 31, 2026, as compared to the three months ended March 31, 2025. The net increase was primarily from winter storm Fern freeze repair expenses of $1,357, partially offset by reduced compensation and research and development expenses.
Current wording
Operating expenses increased $611 in the three months ended June 30, 2026, as compared to the three months ended June 30, 2025. The net increase was primarily from additional expenditures related to Winter Storm Fern of $260 and $281 for expenses incurred from a fire which was safely and quickly contained. Operating expenses increased $1,321 in the six months ended June 30, 2026, as compared to the six months ended June 30, 2025. The net increase was primarily from extraordinary maintenance andrepair expenses of $1,898, partially offset by reduced compensation and research and development expenses.
Previous wording
Other income, net decreased $932 in the three months ended March 31, 2026, as compared to the same period of 2025 primarily from the reduction of interest income. In the current three-month period interest income was $298 as compared to $1,237 in the prior period.
Current wording
Other income, net decreased $1,359 in the three months ended June 30, 2026, as compared to the same period of 2025, primarily from the reduction in interest income. In the current three-month period interest income was $209 as compared to $1,068 in the prior period. Other income, net decreased $2,291 in the six months ended June 30, 2026, as compared to the same period of 2025 primarily from the reduction in interest income. In the current six-month period interest income was $507 as compared to $2,305 in the prior period.
Previous wording
The Company’s income tax provision for the three months ended March 31, 2026, is comprised of immaterial state taxes and miscellaneous items. The income tax benefit for the three months ended March 31, 2025, was comprised of immaterial state taxes and miscellaneous items.
Current wording
The Company’s income tax provision for the three and six months ended June 30, 2026 and 2025, was comprised primarily of an increase in the valuation allowance against net deferred assets, plus immaterial state taxes and miscellaneous items.
Previous wording
Chemical revenue in the three months ended March 31, 2026, increased 110% or $10,267 compared to the three months ended March 31, 2025. Revenue from custom chemicals for the three months ended March 31, 2026 totaled $13,872, a net increase of $5,463 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $4,405. Performance chemicals revenue was $5,760, an increase of $4,804 from the three months ended March 31, 2025 from sales of a new energy market product brought online in the fourth quarter of 2025.
Current wording
Chemical revenue in the three months ended June 30, 2026, increased 56% or $9,230 compared to the three months ended June 30, 2025. Revenue from custom chemicals for the three months ended June 30, 2026 totaled $18,519, a net increase of $4,269 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $4,103. Performance chemicals revenue was $7,330, an increase of $4,961 from the three months ended June 30, 2025 from sales of a new energy market product brought online in the fourth quarter of 2025.
Previous wording
Gross loss for the chemical segment was $2,519 for the three months ended March 31, 2026, an improvement of $3,496 compared to the same period of 2025. The improvement was primarily driven by new product revenue sold into the energy market as noted above.
Current wording
Gross profit for the chemical segment was $4,937 and $2,418 for the three and six months ended June 30, 2026, respectively, an improvement of $3,823 and $7,319, respectively, compared to the same periods of 2025. The improvement was primarily driven by increased sales volumes in the energy market including the new product revenue brought online in the fourth quarter of 2025.
Previous wording
Biofuels revenue in the three months ended March 31, 2026, increased by$4,147 compared to the prior-year period. Theupward trend was primarily attributed to enhanced clarity surrounding the CFPC and record-high final renewable volume obligation (“RVO”) levels. However, these gains were partially offset by lower sales volumes, which were adversely impacted by severe winter weather and geopolitical instability in the fuel markets due to the war with Iran.
Current wording
Biofuels revenue in the three andsix months ended June 30, 2026, increased $ 33,823 and $37,970, respectively, compared to the prior-year periods. Theupward trend was primarily attributed to enhanced clarity surrounding the CFPC and record-high final renewable volume obligation (“RVO”) levels, and to a lesser degree, increased equipment utilization following an extended turnaround in the prior year, six-month period.
Previous wording
A significant portion of our biodiesel sold was to one major customer in the three months ended March 31, 2026, as compared to no major customers in the three months ended March 31, 2025. No assurances can be given that we will continue to sell to such major refiner, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of these customers would have a material adverse effect on our biofuels segment or on us as a whole because: (i) we believe that we could readily sell our biodiesel to other customers on equivalent terms as potential demand from other customers for biodiesel exceeds our production capacity; (ii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short-term purchase orders; and (iii) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Current wording
A significant portion of our biodiesel sold was to two major customers in both the three and six months ended June 30, 2026, as compared to three and two major customers in the three and six months ended June 30, 2025, respectively. No assurances can be given that we will continue to sell to any such major refiner, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of these customers would have a material adverse effect on our biofuels segment or on us as a whole because: (i) we believe that we could readily sell our biodiesel to other customers on equivalent terms as potential demand from other customers for biodiesel exceeds our production capacity; (ii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short-term purchase orders; and (iii) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Previous wording
Biofuel gross loss was $13,339 in the three months ended March 31, 2026, representing an increase of $4,166 compared to the same period in 2025. This increased loss was primarily driven by unfavorable shifts in derivative instruments activity. During the quarter, we recognized a realized loss of $9,141 and an unrealized loss of $2,488, compared to a realized gain of $93 and an unrealized loss of $259 in the prior-year period. While the $9,141 in derivative settlements significantly impacted the current quarter’s gross loss, these costs are generally intended to be recovered once the underlying physical product is sold. This timing difference often creates a temporary disconnect between realized derivative losses and the eventual revenue recognition of the physical inventory.
Current wording
Biofuel gross profit increased $23,594 and $19,428 in the three and six months ended June 30, 2026, respectively, compared to the same periods in 2025. These increases were primarily due to regulatory clarity which improved the segment on both volume and margin inclusive of clarified guidelines on the CFPC. During the quarter, this increase was also partially driven by favorable shifts in derivative instruments activity. In the three months ended June 30, 2026, we recognized a realized loss of $1,383 and an unrealized gain of $3,223 compared to a realized gain of $77 and an unrealized gain of $540 in the prior-year period. While the $1,383 in derivative settlements impacted the current period’s gross profit, these costs are generally intended to be recovered once the underlying physical product is sold. This timing difference often creates a temporary disconnect between realized derivative losses and the eventual revenue recognition of the physical inventory. During the six-month period ended June 30, 2026, gross profit increases were partially offset by unfavorable shifts in derivative activity. In the six months ended June 30, 2026, we recognized a realized loss of $10,523 and an unrealized gain of $735, compared to a realized gain of $170 and an unrealized gain of $281 in the prior year period.
Previous wording
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for the three months ended March 31, 2026 and 2025 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer. These sales were subject to written monthly purchase orders. The product was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill-and-hold customers are similar to other custom chemicals customers. Revenues under bill-and-hold arrangements were$10,378 for the three months ended March 31, 2026. As of March 31, 2026 and December 31, 2025, $5,486 and $5,106 of bill-and-hold revenue had not shipped, respectively.
Current wording
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for the three and six months ended June 30, 2026 and 2025 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer. These sales were subject to written monthly purchase orders. The product was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill-and-hold customers are similar to other custom chemicals customers. Revenues under bill-and-hold arrangements were$13,027 and $23,405 for the three and six months ended June 30, 2026. As of June 30, 2026 and December 31, 2025, $4,357 and $5,106 of bill-and-hold revenue had not shipped, respectively.
Previous wording
Our net cash from operating activities, investing activities, and financing activities for the three months ended March 31, 2026 and 2025 is set forth in the following table.
Current wording
Our net cash from operating activities, investing activities, and financing activities for the six months ended June 30, 2026 and 2025 is set forth in the following table.
Previous wording
Cash used in operating activities was $19,996 in the three months ended March 31, 2026, as compared to $5,395 in the same period of 2025. This increase in cash used was primarily attributable to the change in accounts receivable, including accounts receivable - related parties resulting in a cash outflow of $17,891. Also contributing to the current period's increase in cash used was the change in accrued expenses and other current liabilities of $2,842. Partially offsetting these cash outflows was the change in accounts payable, including accounts payable - related parties, resulting in a cash inflow of $4,432, and the change in inventory of $3,359.
Current wording
Cash used in operating activities was $1,227 in the six months ended June 30, 2026, as compared to $183 in the same period of 2025. This increase in cash used was primarily attributable to the change in inventory of $26,609 and the change in accounts receivable, including accounts receivable - related parties resulting in a cash outflow of $21,643. Also contributing to the current period's increase in cash used was the change in deferred revenue of $3,666, the change in accrued expenses and other current liabilities of $2,429, and the change in other assets of $1,698. Partially offsetting these cash outflows was the change in net income of $23,072, the change in accounts payable, including accounts payable - related parties, resulting in a cash inflow of $16,564, and the change in other noncurrent liabilities of $14,970.
Previous wording
Cash used in investing activities was $6,321 in the three months ended March 31, 2026, as compared to $4,082 in the three months ended March 31, 2025. This $2,239 increase in cash used was primarily due to an increase in capital expenditure of $1,384.
Current wording
Cash used in investing activities was $12,652 in the six months ended June 30, 2026, as compared to $8,585 in the six months ended June 30, 2025. This $4,067 increase in cash used was primarily due to an increase in capital expenditure of $3,900.
Previous wording
Cash used in financing activities was $2,632 and $2,993 in the three months ended March 31, 2026 and 2025, respectively, primarily for payments of dividends on our common stock.
Current wording
Cash used in financing activities was $3,071 and $5,621 in the six months ended June 30, 2026 and 2025, respectively, primarily for payments of dividends on our common stock.
Previous wording
Regular cash dividends of $0.06 per share were paid on our common stock in each quarter of 2025. The declaration of these regular quarterly cash dividends was made in the three months ended December 31, 2024. During the three months ended December 31, 2025, a declaration for cash dividends of $0.06 per share was made for the first quarter of 2026. The cash dividend in the three months ended March 31, 2026 and 2025, amounted to $2,628 and $2,632, respectively. During the three months ended March 31, 2026, a cash dividend of $0.01 per share was declared for the second quarter of 2026.
Current wording
Regular cash dividends of $0.06 per share were paid on our common stock in each quarter of 2025. The declaration of these regular quarterly cash dividends was made in the three months ended December 31, 2024. During the three months ended March 31, 2026, a declaration for cash dividends of $0.01 per share was made for the second quarter of 2026. The cash dividends in the three months ended June 30, 2026 and 2025, amounted to $439 and $2,628, respectively. During the three months ended June 30, 2026, a cash dividend of $0.01 per share was declared for the third quarter of 2026.
Rearranged current paragraphs (1)
Current report — wording carried from elsewhere
Chemical revenue in the six months ended June 30, 2026, increased 75% or $ 19,497 compared to the six months ended June 30, 2025. Revenue from custom chemicals for the six months ended June 30, 2026 totaled $32,391, a net increase of $9,732 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $8,508. Performance chemicals revenue was $13,090, an increase of $9,765 from thesix months ended June 30, 2025 from sales of the new energy market product brought online in the fourth quarter of 2025.